公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2006 | Antitumor Effects of a Novel Phenylbutyrate-Based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer | Kulp, Samuel K.; Chen, Chang-Shi; Wang, Da-Sheng; Chen, Ching-Yu; Chen, Ching-Shih | Clinical Cancer Research | | | |
2008 | Histone deacetylase inhibitors in cancer therapy | Sargeant, Aaron M.; Kulp, Samuel K.; YEN-SHEN LU ; ANN-LII CHENG ; Chen, Ching Shih | Cancer Epigenetics | 0 | | |
2008 | Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors | Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong ; Chen, Ching-Shih | Cancer Research | 48 | 47 | |